Core Points - The legal opinion letter confirms the compliance of the 2025 Annual First Extraordinary General Meeting of YXTT Pharmaceutical Group Co., Ltd. with relevant laws and regulations [2][12] - The meeting was convened by the company's board of directors and followed the proper procedures as outlined in the company's articles of association [3][12] - The voting results indicate that all resolutions presented at the meeting were approved by a significant majority [6][12] Meeting Procedures - The meeting was convened based on a resolution from the 15th meeting of the 6th board of directors held on July 25, 2025 [2] - The notice for the meeting was published in major financial newspapers and online platforms on July 26, 2025 [2] - The meeting took place on August 12, 2025, in Kunming, Yunnan, with both on-site and online voting options available [3] Attendance and Voting - A total of 356 participants attended the meeting, representing 320,257,517 shares, which is 55.7815% of the total shares [5] - Among the attendees, 348 were small investors holding less than 5% of the shares, representing 38,471,623 shares [5] - The voting results showed that 99.9042% of the votes were in favor of the resolutions, with minimal opposition [6][12] Voting Results - The voting results for the resolutions were overwhelmingly positive, with significant support from both large and small shareholders [6][12] - Specific resolutions received votes such as 319,950,817 in favor, 242,400 against, and 64,300 abstentions [6] - The small investors' votes also reflected strong support, with 99.2028% in favor of the resolutions [6][12]